Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Axiom Intelligence Acquisition Corp 1 (AXIN) vs Drugs Made In America Acquisition Corp. (DMAA)

Axiom Intelligence Acquisition Corp 1 and Drugs Made In America Acquisition Corp. are both Shell Companies companies. Axiom Intelligence Acquisition Corp 1 and Drugs Made In America Acquisition Corp. are of similar size ($281.9M and $263.4M).

Valuation

Metric AXIN DMAA Shell Companies median
P/E — — 39.97
P/S — — 12.19
P/B — — 2.01
Price to free cash flow — — 28.89
EV/EBITDA — — —
EV/Sales — — —
Earnings yield — — 1.63%
Free cash flow yield — — (0.79%)

Profitability

Metric AXIN DMAA Shell Companies median
Gross margin — — 71.01%
Operating margin — — 0.00%
Net margin — — 0.00%
Free cash flow margin — — 0.00%
Return on equity — — 1.91%
Return on assets — — 2.03%
Return on invested capital — — 0.00%

Growth

Metric AXIN DMAA Shell Companies median
Revenue growth (TTM) — — —
EPS growth (last fiscal year) — — —
Revenue growth, 5-year CAGR — — —
Net income growth, 5-year CAGR — — 0.00%

Health

Metric AXIN DMAA Shell Companies median
Debt to equity — — 0.00
Current ratio — — 0.08
Net debt to EBITDA — — 0.06

Dividend

Metric AXIN DMAA Shell Companies median
Dividend yield — — —
Payout ratio — — 0.00

Size

Metric AXIN DMAA Shell Companies median
Market cap 281.94m 263.40m 154.76m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack